CNBC Investing Club

Regulatory approvals for AbbVie, J&J bolster the Club investment case

A sign stands outside a Abbvie facility in Cambridge, Massachusetts, May 20, 2021.
Brian Snyder | Reuters

Regulators in Canada and the U.S. have greenlit new product offerings from two Club pharmaceutical giants, AbbVie (ABBV) and Johnson & Johnson (JNJ) — positive developments that validate our investment case in both ho